Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. It provides access to medicines, advance sustainable operations, develop innovative solutions and leverage its collective expertise to connect more people to more products and services through its one-of-a-kind Global Healthcare GatewayTM. Formed in November 2020through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghaiand Hyderabad, India.
Financial Statements
- Click here to download Viatris Inc's Income Statement
- Click here to download Viatris Inc's Balance Sheet
- Click here to download Viatris Inc's Statement of Cash Flows
Key Info
- Industry: Investment Advice
- Sector: Finance and Insurance
- CEO Name:
Key Statistics
- Stock Price: $14.96
- Dividend Yield: 2.1999999999999997%
- Market Capitalization: $17,693,425,676
- Shares Outstanding: 1,209,393,416
- Number of Employees: 2,020
- Trailing 12-Month EPS: $-1.71
- Trailing 12-Month DPS: $0.33
- Payout Ratio: -19.3%
Important Dates
- Next Earnings Date: 2022-02-28
- Next Ex-Dividend Date: 2021-11-22
Price Trends
- Current Stock Price: $14.96
- 52-week high: $18.25
- 52-week low: $11.96
- 200-day moving average: $13.78
- 50-day moving average: $14.08
Performance
- 1-Month Price Return: 8.0%
- 3-Month Price Return: 10.5%
- 6-Month Price Return: 5.7%
- 1-Year Price Return: -11.9%
- 2-Year Price Return: -8.4%
- 5-Year Price Return: -8.4%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast